Greenville Health System

Seneca, South Carolina 29672

0 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Advanced, Androgen Receptor Positive Triple Negative Breast Cancer, Breast Cancer, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Metastatic Breast Cancer, Myelodysplastic Syndrome

Studies at this site

• Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML) — Completed
• Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer — Completed
• Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer — Completed
• Palbociclib in Real World Practice — Completed